English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

The Biology of CRISPR-Cas: Backward and Forward

MPS-Authors

Hille,  Frank
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Richter,  Hagen
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Wong,  Shi Pey
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Bratovič,  Majda
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Ressel,  Sarah
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Charpentier,  Emmanuelle
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018). The Biology of CRISPR-Cas: Backward and Forward. Cell, 172(6), 1239-1259. doi:10.1016/j.cell.2017.11.032.


Cite as: https://hdl.handle.net/21.11116/0000-0008-7C68-9
Abstract
In bacteria and archaea, clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins constitute an adaptive immune system against phages and other foreign genetic elements. Here, we review the biology of the diverse CRISPR-Cas systems and the major progress achieved in recent years in understanding the underlying mechanisms of the three stages of CRISPR-Cas immunity: adaptation, crRNA biogenesis, and interference. The ecology and regulation of CRISPR-Cas in the context of phage infection, the roles of these systems beyond immunity, and the open questions that propel the field forward are also discussed.